RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of GTHP
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Guided Therapeutics, Inc. stock downgraded to Sell Candidate
(Updated on Apr 30, 2024)

Sell candidate since Apr 30, 2024 PDF

No changes to the price of Guided Therapeutics, Inc. stock on the last trading day (Tuesday, 30th Apr 2024). During the last trading day the stock fluctuated 0% from a day low at $0.109 to a day high of $0.109. The price has fallen in 4 of the last 10 days but is still up by 19.65% over the past 2 weeks.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $0.110 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -41.87% during the next 3 months and, with a 90% probability hold a price between $0.0420 and $0.0638 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

GTHP Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Guided Therapeutics, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.113. On a fall, the stock will find some support from the short-term average at $0.101. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Monday, April 29, 2024, and so far it has fallen 0%. Further fall is indicated until a new bottom pivot has been found. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Guided Therapeutics, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.0960 and $0.0916. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Guided Therapeutics, Inc. finds support just below today's level at $0.0960. If this is broken, then the next support from accumulated volume will be at $0.0916 and $0.0873.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 9.40%

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (GTHP) For The Upcoming Trading Day Of Wednesday 1st

For the upcoming trading day on Wednesday, 1st we expect Guided Therapeutics, Inc. to open at $0.109, and during the day (based on 14 day Average True Range), to move between $0.0993 and $0.119, which gives a possible trading interval of +/-$0.0097 (+/-8.88%) up or down from last closing price. If Guided Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 17.75% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.116 (5.96%) than the support at $0.0960 (11.93%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Guided Therapeutics, Inc. stock A Buy?

Guided Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -3.043 Sell Candidate Downgraded

Predicted Opening Price for Guided Therapeutics, Inc. of Wednesday, May 1, 2024

Fair opening price May 1, 2024 Current price
$0.109 ( 0%) $0.109

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for GTHP

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.109 .
R2 0.109 .
R1 0.109 .
Current price: 0.109
Support S1 0.109 .
S2 0.109 .
S3 0.109 .

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.132 21.10 %
R2 0.130 19.27 %
R1 0.116 5.96 %
Current price 0.109
Support S1 0.0960 -11.93%
S2 0.0916 -15.96%
S3 0.0873 -19.91%

FAQ

What is the symbol for Guided Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Guided Therapeutics, Inc. is GTHP and it is traded on the PINK (Pink Sheets).

Should I buy or sell Guided Therapeutics, Inc. Stock?
Guided Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

How to buy Guided Therapeutics, Inc. Stock?
Guided Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Guided Therapeutics, Inc. Stock.

What's the current price of Guided Therapeutics, Inc. Stock?
As of the end of day on the Apr 30, 2024, the price of an Guided Therapeutics, Inc. (GTHP) share was $0.109.

What is the 52-week high and low for Guided Therapeutics, Inc. Stock?
The 52-week high for Guided Therapeutics, Inc. Stock is $0.300 and the 52-week low is $0.0620.

What is the market capitalization of Guided Therapeutics, Inc. Stock?
As of the Apr 30, 2024, the market capitalization of Guided Therapeutics, Inc. is 6.062M.

When is the next earnings date for Guided Therapeutics, Inc.?
The upcoming earnings date for Guided Therapeutics, Inc. is May 13, 2024.
Click to get the best stock tips daily for free!

About Guided Therapeutics, Inc.

Guided Therapeutics. Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its n... GTHP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT